Tyler Technologies Corp/ US9022521051 /
2024-05-10 10:10:00 PM | Chg. +2.92 | Volume | Bid2:00:00 AM | Ask2:00:00 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
484.76USD | +0.61% | 197,162 Turnover: 51.42 mill. |
470.00Bid Size: 100 | 529.85Ask Size: 100 | 20.58 bill.USD | - | 122.72 |
GlobeNewswire
05-09
FOX Factory Performance Vehicle Development Introduces the All-New Black Widow Limited Chevrolet Sil...
GlobeNewswire
05-08
CAULIPOWER, The Better-For-You Brand Reinventing America’s Favorite Comfort Foods, Announces Veteran...
GlobeNewswire
05-07
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire
05-07
Invizyne Technologies Expands Leadership Team Ahead of Proposed Offering and Listing on Nasdaq
GlobeNewswire
05-07
Hey Boo Boo! Three New Yogi Bear’s Jellystone Park Locations are Opening this Summer
GlobeNewswire
05-06
Cribl Joins Wiz Integration Program to Strengthen Security Posture with Data-Driven Insights
GlobeNewswire
05-06
VYNE Therapeutics Announces FDA Clearance of IND Application for VYN202, a Novel BD2-Selective BET I...
GlobeNewswire
05-02
Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for Th...
GlobeNewswire
05-02
WELL Launches its Second-Generation AI powered Physician Co-pilot with Chronic Disease Detection Pow...
GlobeNewswire
05-01
Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing th...
GlobeNewswire
05-01
Redwood Logistics and American Tire Distributors to Display 4PL Orchestration at Gartner Supply Chai...
GlobeNewswire
05-01
Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to D...